Funded Grants

The V Foundation’s grant making model ensures the most promising cancer research projects at state-of-the-art facilities around the country are funded. Cancer research grants are awarded to innovative researchers with the most cutting-edge ideas on how to improve cancer diagnosis methods, prevent cancer recurrences or defeat cancer. 100% of direct donations are used to fund projects we identify as the most likely to help those diagnosed with cancer.

2024
Jianguo Tao, PhD
Defining mechanisms of therapy resistance to CDK9 inhibitor (CDK9i) treatment in aggressive...
Read More
2024
Shiri Gur-Cohen, PhD
Decoding Stem Cell-Niche Dependencies in Driving Tumor Evolution and Therapy Resistance
Read More
2024
Nadine Barrett, PhD, MA, MS
Population Health Navigation: A Comprehensive Intervention to Increase Clinical Trial Participation
Read More
2024
Corina Antal, PhD
Uncovering novel post-transcriptional vulnerabilities in pancreatic cancer
Read More
2024
Noam Auslander, PhD
Fecal microbial biomarkers of immunotherapy benefit and adverse events in melanoma
Read More
2024
Gina Ogilvie, MD
FOCAL MOMENTUM (MicrObiome Monitoring for ElimiNaTion of Cervical Cancer) Study
Read More
2024
Livia Schiavinato Eberlin, PhD
Transforming Cancer Surgery with Medical Mass Spectrometry Technology *One exceptional Adult Translational...
Read More
2024
Xueqiu (Chu) Lin, PhD
Mapping and modeling oncogenic non-coding networks for colorectal cancer risk prediction
Read More
2024
Oriana Damas, MD, MSCTI
Leveraging Microbiome and Metabolomic Strategies to Target DUOX2 Activity for Colorectal Cancer...
Read More
2024
Caroline Bartman, PhD
Targeting vitamin B1 metabolism to starve colorectal cancer
Read More
2024
Melissa Reeves, PhD
Spatial regulation of suppressive macrophages by Cx3cl1 and consequences for anti-tumor immunity
Read More
2024
Christine Eyler, MD, PhD
Deciphering Epigenetic Drivers of Concerted Cell Fate Changes in Rectal Cancer Radiation...
Read More
2024
Alejandro Villarino, PhD
Comprehensive molecular and therapeutic assessment of STAT3-driven T cell malignancies
Read More
2024
Andrea Cercek, MD
Neoadjuvant Botensilimab and Balstilimab in mismatch-repair proficient rectal adenocarcinoma
Read More
2024
Josephine Taverna, M.D.
AXL-STAT3-PD1 targeting of tumor immune microenvironments
Read More
2024
Carla Nowosad, PhD
Tracking and targeting germinal centers in colorectal cancer
Read More